Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Controlled Study to Evaluate the Effectiveness and Safety of CELSTAT as an Adjunct to Hemostasis for Tissue Bleeding in Cardiothoracic, General, and Vascular Surgery.
Conditions
Interventions
CELSTAT
Surgicel Original
Locations
25
United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
University of Florida College of Medicine
Gainesville, Florida, United States
River City Clinical Research
Jacksonville, Florida, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Infectious Disease of Indiana, PSC
Carmel, Indiana, United States
University of Kentucky College of Medicine, Kentucky Clinic
Lexington, Kentucky, United States
Start Date
February 24, 2016
Primary Completion Date
July 21, 2017
Completion Date
October 18, 2017
Last Updated
August 3, 2020
Lead Sponsor
Baxter Healthcare Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions